Advertisement

Inspira Technologies Oxy B.H.N. Ltd. IINN

Set alert

Price alert · IINN

All alert types
1.05 USD 0.00 0.00%

As of Aug 7, 9:30 AM ET

Bid
0.37 × 1
Ask
0.38 × 2
0.9801 Day range 1.06
0.3353 52-week range 1.19
YTD
+16.67%
1 year
+32.91%
Open
1.04
Prev close
1.05
Mkt cap
25.29M
Vol
1.53M
Avg vol
352.44K
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
0.9801
High
1.06
Forward P/E
-1.66
Beta
2.09
Short ratio
1.03
Inst. own
6.03%
Dividend
0.00
Ex-div date
Earnings
Jul 1, 2024
50-d avg
1.29
200-d avg
1.50
1y target
0.00

2Y chart

Chart tools
Interval

Chart is warming up

The two-year price history for IINN has not been loaded yet. Try again in a moment.

Key statistics

Market cap
21.46M
Enterprise value
7.71M
Trailing P/E
0.00
Forward P/E
-1.66
PEG ratio
0.00
Price / sales
0.00
Price / book
3.16
EPS (TTM)
-0.78
Beta
2.09
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
0
Revenue growth
0.00%
Free cash flow
-4.74M
Total cash
7.36M
Total debt
878.00K
Return on equity
-116.54%
Shares outstanding
18.50M
Short % of float
1.13%
50-day average
1.29
200-day average
1.50

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Jul 1, 2024

Expected Jul 1, 2024. Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
IINN Revenue — quarterly 0
2020-Q3 20202020-Q4 20202021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q4 20222023-Q1 20232023-Q2 2023
IINN Net income — quarterly -9.21M
2020-Q3 20202020-Q4 20202021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q4 20222023-Q1 20232023-Q2 2023

Earnings

IINN recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Jul 1, 2024Mar 1, 20240.00———
Mar 29, 2024Dec 1, 20230.00———

About Inspira Technologies Oxy B.H.N. Ltd.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of proprietary life support technology for the treatment of acute respiratory failure. Its lead product is the INSPIRA augmented respiration technology (Gen 2) device, a life support designed to provide Adaptive Blood Oxygenation that to elevate and stabilize declining oxygen saturation levels. The company has a strategic collaboration with Westchester Medical Center to advance critical patient care with the deployment of Inspira's proprietary INSPIRA ART100 systems. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.

Sector
Healthcare
Industry
Medical Devices
Country
Israel

News

Your note

Sign in to keep a note on IINN — it syncs with the Stock Master app.

Institution ownership

IINN institution ownership
Holder% heldSharesValueReported
IEQ Capital, LLC0.30%51,94960.26KSep 29, 2024
Citadel Advisors Llc0.10%16,60419.26KSep 29, 2024
Renaissance Technologies, LLC0.09%15,09017.50KSep 29, 2024
Avantax Advisory Services, Inc.0.09%15,00017.40KSep 29, 2024
Xtx Topco Ltd0.09%14,92117.31KSep 29, 2024
Laidlaw Wealth Management LLC0.08%13,50015.66KSep 29, 2024

Fund ownership

IINN fund ownership
Holder% heldSharesValueReported
Fidelity NASDAQ Composite Index Fund0.02%2,9243.39KOct 30, 2024
Advertisement